Effect of MCT Emulsification on Ketogenesis in Human Adults

NCT02409927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-02-11

Study results available
· View outcomes & findings →

Summary

Lower brain glucose uptake is present before the onset of cognitive deterioration and may increase the risk of cognitive decline in Alzheimer's disease. Ketones are the brain's main alternative energy substrates. Medium-chain triglycerides (MCT) are rapidly beta-oxidized and are ketogenic. Large doses of MCT oil are linked to gastro-intestinal side effects due to incomplete absorption so the investigators examined whether homogenisation into a skim milk matrix (MCT-H) would both improve ketogenesis and reduce side-effects compared to MCT taken without homogenisation into a matrix (bulk MCT \[MCT-B\]).

Hypotheses: (i) MCT-H will be better absorbed compared to MCT-B, so MCT-H will result in higher ketonemia and lower side effects in healthy adults. (ii) The effects of MCT-B and MCT-H on ketogenesis will be dose-dependent.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

MCT oil 10g

10 g of pure MCT oil mixed with skim milk in a standardized breakfast

DIETARY_SUPPLEMENT

MCT homogenate 10g

10g provided by 10% MCT homogenate mixed with skim milk in a standardized breakfast

DIETARY_SUPPLEMENT

Control

vehicule (skim milk) with a standardized breakfast

DIETARY_SUPPLEMENT

MCT oil 20g

20g of pure MCT oil mixed with skim milk in a standardized breakfast

DIETARY_SUPPLEMENT

MCT homogenate 20g

20g provided by 10% MCT homogenate mixed with skim milk in a standardized breakfast

DIETARY_SUPPLEMENT

MCT oil 30g

30g of 100% pure MCT oil mixed with skim milk in a standardized breakfast

DIETARY_SUPPLEMENT

MCT homogenate 30g

30g provided by 10% MCT homogenate mixed with skim milk in a standardized breakfast

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Stephen C Cunnane, PhD · Université de Sherbrooke

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-09-30
Completion
2014-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02409927 on ClinicalTrials.gov